Cryptococcosis Therapeutics Market, By Type, By Route of Administration, By Therapeutic Area, By Distribution Channel, By Country, and By Region -Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033

Description

Cryptococcosis Therapeutics Market size was valued at US$ 1,470.8 Million in 2025, expanding at a CAGR of 6.1% from 2026 to 2033.

Cryptococcosis therapeutics help in the treatment of a serious systemic infection that is brought about by the fungi with the aid of potent antifungal agents intravenously and neurological testing in order to manage intracranial pressure. This method is comprised of three main steps. The first step of the method involves induction, in which the use of two powerful drugs, amphotericin B and flucytosine, is employed in an attempt to kill the organisms. The second phase includes the consolidation phase, which involves the administration of fluconazole to kill the organism. The third phase involves reducing the risk of recurrence through the reduction of relapse. This comprehensive treatment approach improves survival outcomes and reduces recurrence risks in cryptococcal infections.

Cryptococcosis Therapeutics Market- Market Dynamics

Advancements In Diagnostic Techniques To Boost Market Expansion

Advancements in diagnostic techniques are driving the diagnostic imaging market, as newer technologies and new techniques such as MRI, CT, PET, ultrasound, and imaging using AI technology provide for rapid and accurate diagnosis of diseases. For example, in February 2026, the Medicines and Healthcare Products Regulatory Agency (MHRA), per the UK government, reported a 17% growth in the number of clinical investigation trials in the UK, which means that more applications have been approved in 2025 than in any other year before. Moreover, there has been a rise in the number of neurotechnology investigations (both diagnostics and brain research) in a year compared to the past two years; the increment has accounted for nearly 25% of their total applications. These advancements are improving diagnostic accuracy, enabling earlier detection, and supporting more effective patient care.

Cryptococcosis Therapeutics Market- Segmentation Analysis:

The Global Cryptococcosis Therapeutics Market is segmented on the basis of Type, Route of Administration, Therapeutic Area, Distribution Channel, and Region.

Among the given types, antifungal agents hold a major share under the type segment because of their proven use as the first-line treatment for the disease. The drugs used in the treatment include amphotericin B, flucytosine, and fluconazole. In March 2025, Pfizer Inc. was granted Australian approval of its antifungal agent known as CRESEMBA(R) (isavuconazonium sulfate). This antifungal belongs to the azole family that acts against invasive aspergillosis and mucormycosis. These will help in increasing the antifungal agents segment.

HIV/AIDS holds the key position in the Cryptococcosis Therapeutics Market under the Therapeutic Area segment, driven by the high incidence of cryptococcal disease among people with advanced HIV/AIDS and the significant need for antifungal treatment in this population. For instance, in August 2026, according to the Delhi State AIDS Control Society (Gov.), NACO HIV reported that Delhi had an HIV prevalence of 0.32% among the aged 15-49 years, which amounted to approximately 58,563 people living with HIV in the state. In Delhi the estimations suggested around 2,961 new HIV infections per year and approximately 1,121 deaths due to HIV per year. It shows that the burden of HIV/AIDS is continually increasing in the region. This rising HIV/AIDS burden is expected to increase demand for effective cryptococcosis therapeutics among affected patients.

Cryptococcosis Therapeutics Market- Geographical Insights

North America is home to leading pharmaceutical companies and research institutions that actively participate in creating treatments for cryptococcosis. There are some joint ventures between the public health institutions and the pharmaceutical firms. For example, in January 2026, according to the World Health Organization (WHO), more than 150 nations have adopted their national lists of essential medicines using the model list issued by the WHO, meaning that more than 150 countries use the National List of Essential Medicines developed based on the WHO Model List. The WHO Model List of Essential Medicines 2025 includes more than 520 medicines, of which 374 are children's medicines. These initiatives strengthen treatment development, improve access, and support better cryptococcosis management across North America.

Cryptococcosis Therapeutics Market- Competitive Landscape:

The Cryptococcosis Therapeutics market is also working towards making acquisitions, particularly in the drug categories and geographies. The leading companies operating in this market are Astellas Pharma Inc., Bristol-Myers Squibb Company, Glenmark Pharmaceuticals, Merck & Co., Inc., and Pfizer Inc., and these companies are looking towards increasing the efficacy of treatment of the disease that causes cryptococcosis. In November 2025, Merck & Co., Inc. entered into a partnership with Cidara Therapeutics for strengthening its antifungal product portfolio through CD421, which is an echinocandin in development for the treatment of serious fungal infections. These strategic initiatives are expected to strengthen antifungal treatment options and support continued market growth.

Recent Developments:

In February 2026, the investigational oral amphotericin B drug MAT2203 from Matinas BioPharma was featured in a published clinical case report for its successful treatment of cryptococcal meningitis, proving its worth as an oral drug for the treatment of cryptococcosis.

In September 2025, Basilea Pharmaceutica AG received an additional USD 25 million grant funding from the Biomedical Advanced Research and Development Authority (BARDA) for the development of its novel antifungal agents fosmanogepix and BAL2062 for treating tough-to-treat cases of fungal infection, including cryptococcosis.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CRYPTOCOCCOSIS THERAPEUTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Gilead Sciences, Inc.
Merck & Co., Inc.
Asahi Kasei Pharma Corporation
Sun Pharmaceutical Industries Limited
Dr. Reddy's Laboratories Ltd.
Cipla Limited
Basilea Pharmaceutica AG
F2G Limited
Matinas BioPharma Holdings Inc.
Lupin Limited
Bausch Health Companies Inc.
Teva Pharmaceutical Industries Ltd.
Viatris Inc.
Amplyx Pharmaceuticals, Inc.
Flynn Pharma Ltd.
NuCare Pharmaceuticals, Inc.
Sanofi
Abbott Laboratories
Others

GLOBAL CRYPTOCOCCOSIS THERAPEUTICS MARKET, BY TYPE- MARKET ANALYSIS, 2020 - 2033

Combination Therapy
Immunotherapy
Antifungal Agents

GLOBAL CRYPTOCOCCOSIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2020 - 2033

Intravenous
Topical
Oral

GLOBAL CRYPTOCOCCOSIS THERAPEUTICS MARKET, BY THERAPEUTIC AREA- MARKET ANALYSIS, 2020 - 2033

Transplantation
Immunocompromised Patients
HIV/AIDS

GLOBAL CRYPTOCOCCOSIS THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2020 - 2033

Pharmacies
Online Pharmacies
Hospitals

GLOBAL CRYPTOCOCCOSIS THERAPEUTICS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Denmark
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Taiwan
Vietnam
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Iran
Qatar
Rest of MEA

Product Code: ANV7389

1. Cryptococcosis Therapeutics Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
2.2. Competitive Insights

3. Cryptococcosis Therapeutics Key Market Trends

3.1. Cryptococcosis Therapeutics Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Cryptococcosis Therapeutics Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Cryptococcosis Therapeutics Market Opportunities
3.4. Cryptococcosis Therapeutics Market Future Trends

4. Cryptococcosis Therapeutics Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Cryptococcosis Therapeutics Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Cryptococcosis Therapeutics Market Landscape

6.1. Cryptococcosis Therapeutics Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Cryptococcosis Therapeutics Market - By Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Type, 2025 & 2033 (%)
- 7.1.2. Combination Therapy
- 7.1.3. Immunotherapy
- 7.1.4. Antifungal Agents

8. Cryptococcosis Therapeutics Market - By Route of Administration

8.1. Overview
- 8.1.1. Segment Share Analysis, By Route of Administration, 2025 & 2033 (%)
- 8.1.2. Intravenous
- 8.1.3. Topical
- 8.1.4. Oral

9. Cryptococcosis Therapeutics Market - By Therapeutic Area

9.1. Overview
- 9.1.1. Segment Share Analysis, By Therapeutic Area, 2025 & 2033 (%)
- 9.1.2. Transplantation
- 9.1.3. Immunocompromised Patients
- 9.1.4. HIV/AIDS

10. Cryptococcosis Therapeutics Market - By Distribution Channel

10.1. Overview
- 10.1.1. Segment Share Analysis, By Distribution Channel, 2025 & 2033 (%)
- 10.1.2. Pharmacies
- 10.1.3. Online Pharmacies
- 10.1.4. Hospitals

11. Cryptococcosis Therapeutics Market - By Geography

11.1. Introduction
- 11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
11.2. North America
- 11.2.1. Overview
- 11.2.2. Cryptococcosis Therapeutics Key Manufacturers in North America
- 11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.2.4. North America Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 11.2.5. North America Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.2.6. North America Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
- 11.2.7. North America Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.2.8. U.S.
  - 11.2.8.1. Overview
  - 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.2.8.3. U.S. Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.2.8.4. U.S. Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 11.2.8.5. U.S. Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 11.2.8.6. U.S. Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.2.9. Canada
  - 11.2.9.1. Overview
  - 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.2.9.3. Canada Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.2.9.4. Canada Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 11.2.9.5. Canada Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 11.2.9.6. Canada Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
11.3. Europe
- 11.3.1. Overview
- 11.3.2. Cryptococcosis Therapeutics Key Manufacturers in Europe
- 11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.3.4. Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 11.3.5. Europe Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.3.6. Europe Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
- 11.3.7. Europe Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.3.8. Germany
  - 11.3.8.1. Overview
  - 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.8.3. Germany Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.3.8.4. Germany Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 11.3.8.5. Germany Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 11.3.8.6. Germany Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.3.9. UK
  - 11.3.9.1. Overview
  - 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.9.3. UK Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.3.9.4. UK Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 11.3.9.5. UK Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 11.3.9.6. UK Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.3.10. France
  - 11.3.10.1. Overview
  - 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.10.3. France Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.3.10.4. France Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 11.3.10.5. France Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 11.3.10.6. France Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.3.11. Italy
  - 11.3.11.1. Overview
  - 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.11.3. Italy Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.3.11.4. Italy Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 11.3.11.5. Italy Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 11.3.11.6. Italy Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.3.12. Spain
  - 11.3.12.1. Overview
  - 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.12.3. Spain Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.3.12.4. Spain Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 11.3.12.5. Spain Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 11.3.12.6. Spain Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.3.13. The Netherlands
  - 11.3.13.1. Overview
  - 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.13.3. The Netherlands Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.3.13.4. The Netherlands Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 11.3.13.5. The Netherlands Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 11.3.13.6. The Netherlands Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.3.14. Sweden
  - 11.3.14.1. Overview
  - 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.14.3. Sweden Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.3.14.4. Sweden Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 11.3.14.5. Sweden Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 11.3.14.6. Sweden Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.3.15. Russia
  - 11.3.15.1. Overview
  - 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.15.3. Russia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.3.15.4. Russia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 11.3.15.5. Russia Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 11.3.15.6. Russia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.3.16. Poland
  - 11.3.16.1. Overview
  - 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.16.3. Poland Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.3.16.4. Poland Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 11.3.16.5. Poland Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 11.3.16.6. Poland Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.3.17. Denmark
  - 11.3.17.1. Overview
  - 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.17.3. Poland Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.3.17.4. Denmark Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 11.3.17.5. Denmark Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 11.3.17.6. Denmark Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.3.18. Rest of Europe
  - 11.3.18.1. Overview
  - 11.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.18.3. Rest of the Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.3.18.4. Rest of the Europe Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 11.3.18.5. Rest of the Europe Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 11.3.18.6. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
11.4. Asia Pacific (APAC)
- 11.4.1. Overview
- 11.4.2. Cryptococcosis Therapeutics Key Manufacturers in Asia Pacific
- 11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.4.4. APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 11.4.5. APAC Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.4.6. APAC Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
- 11.4.7. APAC Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.4.8. China
  - 11.4.8.1. Overview
  - 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.8.3. China Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.4.8.4. China Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 11.4.8.5. China Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 11.4.8.6. China Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.4.9. India
  - 11.4.9.1. Overview
  - 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.9.3. India Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.4.9.4. India Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 11.4.9.5. India Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 11.4.9.6. India Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.4.10. Japan
  - 11.4.10.1. Overview
  - 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.10.3. Japan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.4.10.4. Japan Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 11.4.10.5. Japan Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 11.4.10.6. Japan Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.4.11. South Korea
  - 11.4.11.1. Overview
  - 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.11.3. South Korea Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.4.11.4. South Korea Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 11.4.11.5. South Korea Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 11.4.11.6. South Korea Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.4.12. Australia
  - 11.4.12.1. Overview
  - 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.12.3. Australia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.4.12.4. Australia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 11.4.12.5. Australia Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 11.4.12.6. Australia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.4.13. Indonesia
  - 11.4.13.1. Overview
  - 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.13.3. Indonesia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.4.13.4. Indonesia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 11.4.13.5. Indonesia Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 11.4.13.6. Indonesia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.4.14. Thailand
  - 11.4.14.1. Overview
  - 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.14.3. Thailand Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.4.14.4. Thailand Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 11.4.14.5. Thailand Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 11.4.14.6. Thailand Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.4.15. Philippines
  - 11.4.15.1. Overview
  - 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.15.3. Philippines Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.4.15.4. Philippines Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 11.4.15.5. Philippines Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 11.4.15.6. Philippines Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.4.16. Taiwan
  - 11.4.16.1. Overview
  - 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.16.3. Taiwan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.4.16.4. Taiwan Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 11.4.16.5. Taiwan Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 11.4.16.6. Taiwan Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.4.17. Vietnam
  - 11.4.17.1. Overview
  - 11.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.17.3. Vietnam Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.4.17.4. Vietnam Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 11.4.17.5. Vietnam Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 11.4.17.6. Vietnam Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.4.18. Rest of APAC
  - 11.4.18.1. Overview
  - 11.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.18.3. Rest of APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.4.18.4. Rest of APAC Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 11.4.18.5. Rest of APAC Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 11.4.18.6. Rest of APAC Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
11.5. Latin America (LATAM)
- 11.5.1. Overview
- 11.5.2. Cryptococcosis Therapeutics Key Manufacturers in Latin America
- 11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.5.4. LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 11.5.5. LATAM Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.5.6. LATAM Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
- 11.5.7. LATAM Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.5.8. Brazil
  - 11.5.8.1. Overview
  - 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.5.8.3. Brazil Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.5.8.4. Brazil Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 11.5.8.5. Brazil Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 11.5.8.6. Brazil Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.5.9. Mexico
  - 11.5.9.1. Overview
  - 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.5.9.3. Mexico Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.5.9.4. Mexico Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 11.5.9.5. Mexico Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 11.5.9.6. Mexico Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.5.10. Argentina
  - 11.5.10.1. Overview
  - 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.5.10.3. Argentina Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.5.10.4. Argentina Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 11.5.10.5. Argentina Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 11.5.10.6. Argentina Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.5.11. Colombia
  - 11.5.11.1. Overview
  - 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.5.11.3. Colombia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.5.11.4. Colombia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 11.5.11.5. Colombia Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 11.5.11.6. Colombia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.5.12. Rest of LATAM
  - 11.5.12.1. Overview
  - 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.5.12.4. Rest of LATAM Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 11.5.12.5. Rest of LATAM Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 11.5.12.6. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
11.6. Middle East and Africa (MEA)
- 11.6.1. Overview
- 11.6.2. Cryptococcosis Therapeutics Key Manufacturers in Middle East and Africa
- 11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.6.4. MEA Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 11.6.5. MEA Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.6.6. MEA Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
- 11.6.7. MEA Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.6.8. Saudi Arabia
  - 11.6.8.1. Overview
  - 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.6.8.4. Saudi Arabia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 11.6.8.5. Saudi Arabia Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 11.6.8.6. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.6.9. United Arab Emirates
  - 11.6.9.1. Overview
  - 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.6.9.4. United Arab Emirates Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 11.6.9.5. United Arab Emirates Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 11.6.9.6. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.6.10. Israel
  - 11.6.10.1. Overview
  - 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.6.10.3. Israel Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.6.10.4. Israel Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 11.6.10.5. Israel Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 11.6.10.6. Israel Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.6.11. Turkey
  - 11.6.11.1. Overview
  - 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.6.11.3. Turkey Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.6.11.4. Turkey Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 11.6.11.5. Turkey Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 11.6.11.6. Turkey Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.6.12. Algeria
  - 11.6.12.1. Overview
  - 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.6.12.3. Algeria Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.6.12.4. Algeria Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 11.6.12.5. Algeria Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 11.6.12.6. Algeria Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.6.13. Egypt
  - 11.6.13.1. Overview
  - 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.6.13.3. Egypt Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.6.13.4. Egypt Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 11.6.13.5. Egypt Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 11.6.13.6. Egypt Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.6.14. Iran
  - 11.6.14.1. Overview
  - 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.6.14.3. Iran Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.6.14.4. Iran Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 11.6.14.5. Iran Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 11.6.14.6. Iran Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.6.15. Qatar
  - 11.6.15.1. Overview
  - 11.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.6.15.3. Qatar Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.6.15.4. Qatar Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 11.6.15.5. Qatar Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 11.6.15.6. Qatar Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.6.16. Rest of MEA
  - 11.6.16.1. Overview
  - 11.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.6.16.3. Rest of MEA Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.6.16.4. Rest of MEA Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
  - 11.6.16.5. Rest of MEA Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 11.6.16.6. Rest of MEA Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)

12. Key Vendor Analysis- Cryptococcosis Therapeutics Industry

12.1. Competitive Benchmarking
- 12.1.1. Competitive Dashboard
- 12.1.2. Competitive Positioning
12.2. Company Profiles
- 12.2.1. Gilead Sciences, Inc.
- 12.2.2. Merck & Co., Inc.
- 12.2.3. Asahi Kasei Pharma Corporation
- 12.2.4. Sun Pharmaceutical Industries Limited
- 12.2.5. Dr. Reddy's Laboratories Ltd.
- 12.2.6. Cipla Limited
- 12.2.7. Basilea Pharmaceutica AG
- 12.2.8. F2G Limited
- 12.2.9. Matinas BioPharma Holdings Inc.
- 12.2.10. Lupin Limited
- 12.2.11. Bausch Health Companies Inc.
- 12.2.12. Teva Pharmaceutical Industries Ltd.
- 12.2.13. Viatris Inc.
- 12.2.14. Amplyx Pharmaceuticals, Inc.
- 12.2.15. Flynn Pharma Ltd.
- 12.2.16. NuCare Pharmaceuticals, Inc.
- 12.2.17. Sanofi
- 12.2.18. Abbott Laboratories
- 12.2.19. Others

13. 360 Degree AnalystView

14. Appendix

14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us